Effects of Active Immunization with a Pneumococcal Surface Protein (PspA) and of Locally Applied Antibodies in Experimental Otitis Media
Overview
Authors
Affiliations
An experimental rat model for Streptococcus pneumoniae otitis media was used to investigate passive protection by anti-type 3 capsular antibodies and effects of immunization with pneumococcal surface protein A (PspA). Anti-type 3 antibodies instilled into the middle ear reduced purulent otitis media as compared to control animals (p = 0.015). Secondly, after immunization with PspA, the right middle ear was inoculated with S. pneumoniae type 6A in a dose calibrated to induce purulent otitis media. There was an anti-PspA antibody response in all rats immunized and a reduction in signs of purulent otitis media as compared to control animals (p = 0.026). Thus, purulent (acute) otitis media can be reduced by local application of antibodies in the middle ear and also by immunization with a non-type-specific pneumococcal protein, PspA.
Ahmad I, Burton R, Nahm M, Ejaz H, Arshad R, Younis B PLoS One. 2024; 19(8):e0306921.
PMID: 39121085 PMC: 11315336. DOI: 10.1371/journal.pone.0306921.
A subunit vaccine against pneumonia: targeting S and .
Rafi M, Al-Khafaji K, Mandal S, Meghla N, Biswas P, Rahman M Netw Model Anal Health Inform Bioinform. 2023; 12(1):21.
PMID: 37096010 PMC: 10115389. DOI: 10.1007/s13721-023-00416-3.
Pneumococcal Choline-Binding Proteins Involved in Virulence as Vaccine Candidates.
Sempere J, Llamosi M, Del Rio Menendez I, Ruiz B, Domenech M, Gonzalez-Camacho F Vaccines (Basel). 2021; 9(2).
PMID: 33672701 PMC: 7924319. DOI: 10.3390/vaccines9020181.
Genschmer K, Vadesilho C, McDaniel L, Park S, Hale Y, Miyaji E mSphere. 2019; 4(6).
PMID: 31826968 PMC: 6908419. DOI: 10.1128/mSphere.00589-19.
Yun K, Choi E, Lee H PLoS One. 2017; 12(11):e0183968.
PMID: 29131872 PMC: 5683564. DOI: 10.1371/journal.pone.0183968.